Annual CFI
-$257.71 M
-$326.01 M-477.32%
November 30, 2024
Summary
- As of February 8, 2025, NRIX annual cash flow from investing activities is -$257.71 million, with the most recent change of -$326.01 million (-477.32%) on November 30, 2024.
- During the last 3 years, NRIX annual CFI has fallen by -$149.46 million (-138.07%).
- NRIX annual CFI is now -477.32% below its all-time high of $68.30 million, reached on November 30, 2023.
Performance
NRIX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$140.82 M
-$119.48 M-559.90%
November 30, 2024
Summary
- As of February 8, 2025, NRIX quarterly cash flow from investing activities is -$140.82 million, with the most recent change of -$119.48 million (-559.90%) on November 30, 2024.
- Over the past year, NRIX quarterly CFI has dropped by -$176.33 million (-496.52%).
- NRIX quarterly CFI is now -355.99% below its all-time high of $55.01 million, reached on November 30, 2022.
Performance
NRIX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$257.71 M
-$126.44 M-96.32%
November 30, 2024
Summary
- As of February 8, 2025, NRIX TTM cash flow from investing activities is -$257.71 million, with the most recent change of -$126.44 million (-96.32%) on November 30, 2024.
- Over the past year, NRIX TTM CFI has dropped by -$345.46 million (-393.70%).
- NRIX TTM CFI is now -287.18% below its all-time high of $137.68 million, reached on August 31, 2023.
Performance
NRIX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
NRIX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -477.3% | -496.5% | -393.7% |
| 3 y3 years | -138.1% | -976.4% | -8066.4% |
| 5 y5 years | -3132.6% | -976.4% | -8066.4% |
NRIX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -477.3% | at low | -356.0% | at low | -287.2% | at low |
| 5 y | 5-year | -477.3% | at low | -356.0% | at low | -287.2% | +11.8% |
| alltime | all time | -477.3% | at low | -356.0% | at low | -287.2% | +11.8% |
Nurix Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Nov 2024 | -$257.71 M(-477.3%) | -$140.82 M(+559.9%) | -$257.71 M(+96.3%) |
| Aug 2024 | - | -$21.34 M(-83.7%) | -$131.27 M(+50.6%) |
| May 2024 | - | -$131.07 M(-469.1%) | -$87.16 M(-199.3%) |
| Feb 2024 | - | $35.51 M(-347.1%) | $87.75 M(+28.5%) |
| Nov 2023 | $68.30 M(+151.1%) | -$14.37 M(-163.1%) | $68.30 M(-50.4%) |
| Aug 2023 | - | $22.77 M(-48.0%) | $137.68 M(+165.6%) |
| May 2023 | - | $43.83 M(+172.8%) | $51.83 M(+1502.2%) |
| Feb 2023 | - | $16.07 M(-70.8%) | $3.23 M(-88.1%) |
| Nov 2022 | $27.20 M | $55.01 M(-187.2%) | $27.20 M(-142.3%) |
| Aug 2022 | - | -$63.08 M(+1223.7%) | -$64.33 M(+377.0%) |
| May 2022 | - | -$4.76 M(-111.9%) | -$13.49 M(-79.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Feb 2022 | - | $40.03 M(-209.6%) | -$65.83 M(-39.2%) |
| Nov 2021 | -$108.25 M(-57.4%) | -$36.52 M(+198.6%) | -$108.25 M(-44.9%) |
| Aug 2021 | - | -$12.23 M(-78.6%) | -$196.29 M(-32.8%) |
| May 2021 | - | -$57.11 M(+2292.5%) | -$292.14 M(+23.1%) |
| Feb 2021 | - | -$2.39 M(-98.1%) | -$237.37 M(-6.7%) |
| Nov 2020 | -$254.40 M(-3093.7%) | -$124.56 M(+15.2%) | -$254.40 M(+95.9%) |
| Aug 2020 | - | -$108.08 M(+4526.8%) | -$129.84 M(+496.7%) |
| May 2020 | - | -$2.34 M(-88.0%) | -$21.76 M(+12.0%) |
| Feb 2020 | - | -$19.42 M | -$19.42 M |
| Nov 2019 | $8.50 M(-78.8%) | - | - |
| Nov 2018 | $39.99 M | - | - |
FAQ
- What is Nurix Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Nurix Therapeutics?
- What is Nurix Therapeutics annual CFI year-on-year change?
- What is Nurix Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Nurix Therapeutics?
- What is Nurix Therapeutics quarterly CFI year-on-year change?
- What is Nurix Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Nurix Therapeutics?
- What is Nurix Therapeutics TTM CFI year-on-year change?
What is Nurix Therapeutics annual cash flow from investing activities?
The current annual CFI of NRIX is -$257.71 M
What is the all time high annual CFI for Nurix Therapeutics?
Nurix Therapeutics all-time high annual cash flow from investing activities is $68.30 M
What is Nurix Therapeutics annual CFI year-on-year change?
Over the past year, NRIX annual cash flow from investing activities has changed by -$326.01 M (-477.32%)
What is Nurix Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of NRIX is -$140.82 M
What is the all time high quarterly CFI for Nurix Therapeutics?
Nurix Therapeutics all-time high quarterly cash flow from investing activities is $55.01 M
What is Nurix Therapeutics quarterly CFI year-on-year change?
Over the past year, NRIX quarterly cash flow from investing activities has changed by -$176.33 M (-496.52%)
What is Nurix Therapeutics TTM cash flow from investing activities?
The current TTM CFI of NRIX is -$257.71 M
What is the all time high TTM CFI for Nurix Therapeutics?
Nurix Therapeutics all-time high TTM cash flow from investing activities is $137.68 M
What is Nurix Therapeutics TTM CFI year-on-year change?
Over the past year, NRIX TTM cash flow from investing activities has changed by -$345.46 M (-393.70%)